Getinge AB Stock

Equities

GETI B

SE0000202624

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm 11:29:35 2024-04-16 am EDT 5-day change 1st Jan Change
216.1 SEK +0.84% Intraday chart for Getinge AB -0.18% -3.66%
Sales 2024 * 33.95B 3.1B Sales 2025 * 35.61B 3.25B Capitalization 58.37B 5.33B
Net income 2024 * 2.68B 245M Net income 2025 * 3.24B 296M EV / Sales 2024 * 1.9 x
Net Debt 2024 * 6.3B 575M Net Debt 2025 * 4.29B 392M EV / Sales 2025 * 1.76 x
P/E ratio 2024 *
22.1 x
P/E ratio 2025 *
18.1 x
Employees 11,739
Yield 2024 *
2.18%
Yield 2025 *
2.44%
Free-Float 79.06%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.37%
1 week-0.79%
Current month-0.28%
1 month+2.92%
3 months-3.07%
6 months+5.60%
Current year-4.24%
More quotes
1 week
209.30
Extreme 209.3
219.80
1 month
203.50
Extreme 203.5
219.80
Current year
193.05
Extreme 193.05
233.80
1 year
174.20
Extreme 174.2
275.20
3 years
174.20
Extreme 174.2
431.60
5 years
111.90
Extreme 111.9
431.60
10 years
74.74
Extreme 74.74
431.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 17-04-30
Director of Finance/CFO - 22-09-14
Chairman 63 96-12-31
Members of the board TitleAgeSince
Director/Board Member 68 06-12-31
Director/Board Member 73 88-12-31
Chairman 63 96-12-31
More insiders
Date Price Change Volume
24-04-16 216.1 +0.84% 906,781
24-04-15 214.3 +2.19% 766,498
24-04-12 209.7 -1.60% 546,037
24-04-11 213.1 +0.28% 998,758
24-04-10 212.5 -1.85% 884,433

Delayed Quote Nasdaq Stockholm, April 16, 2024 at 07:47 am EDT

More quotes
Getinge AB is the world's leader in producing and marketing medical equipment intended to health care facilities (clinics, hospitals, rest homes, etc.). Net sales break down by family of products as follows: - medical systems (57.4%): equipment for operating rooms (primarily tables and lighting systems), ventilators and heart and lung machines, etc.; - hospital sterilization equipment (29.4%); - contamination prevention equipment (13.2%): in the fields of biopharmaceutical production, biomedical research, manufacturing of medical devices and laboratory applications. Net sales break down by source of income into sales of equipment (45.3%), consumables (37.1%), services and spare parts (17.6%). At the end of 2021, the group had 20 production sites worldwide. Net sales are distributed geographically as follows: Sweden (1.8%), Europe/Middle East/Africa (35.8%), Americas (37.9%) and Asia/Pacific (24.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
214.3 SEK
Average target price
225.5 SEK
Spread / Average Target
+5.23%
Consensus
  1. Stock Market
  2. Equities
  3. GETI B Stock